Evidence boundary No published human randomized trial has evaluated long-term injectable GHK-Cu for skin, hair, or wound endpoints
Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor
In a 2001 study published in Endocrinology , Heffernan and colleagues reported that chronic AOD-9604 administration reduced body weight gain, decreased adipose tissue mass, and increased fat oxidation in obese mice without altering IGF-1 levels or glucose metabolism effects that were abolished in beta3 adrenergic receptor (3-AR) knockout mice, implicating 3-AR signaling as the mechanism of action [1]
This is an area where future research will be critically important
Believe it or not, deficiencies in certain vitamins and minerals can actually suppress your appetite, making it incredibly difficult to consume enough calories
Bacteriostatic water is the recommended reconstitution medium for BPC-157, TB-500, CJC-1295, Ipamorelin, Epithalon, GHK-Cu, and virtually all other lyophilized research peptides
